Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Topchoice Medical Corporation (600763.SS)
CNY36.09
+1.15 (+3.29%)
CN SHH Healthcare Medical - Care Facilities
Address
Building 5 310023
Hangzhou, CN
Hangzhou, CN
CEO
Yi Wang
Website
tcmedical.com.cn
IPO
1996-10-30
ISIN CNE000000MZ8
Description
Topchoice Medical Corporation operates as a healthcare provider across China, specializing in various medical fields. Its primary focus areas encompass dental services, reproductive health, and ophthalmology. The company manages a substantial network of medical facilities, including around 32 dental hospitals and several assisted reproductive medical institutions. Additionally, Topchoice Medical oversees Tongze Dental College, a non-profit organization dedicated to educational training within the dental sector. Founded in 1995 and headquartered in Hangzhou, China, the company underwent a name change in November 2019, transitioning from its former identity as Topchoice Medical Investment Co., Inc.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY36.09
+1.15 (+3.29%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
8M
Beta
0.51
Float Shares
202.51M
Free Float %
45.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.72% | +1.19% | -11.31% | -26.02% | -11.03% | -6.96% | -9.46% | -52.73% | -85.07% | +97.00% | +965.81% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
36.09
DCF (Unlevered)
30.59
-15.2%
DCF (Levered)
24.05
-33.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
57% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 3 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
Quality scores
Altman Z-Score
8.75
Safe zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
4 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+1.4% Q1'26: +1.4% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+0.0% Q1'26: +0.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+17.5% Q1'26: +14.7% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+23.8% ★ Q1'26: +31.6% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+11.6% ★ Q1'26: +17.0% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%-0.1% ★ Q1'26: +1.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1.16× ★ Q1'26: 1.20× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 10 Rev. Ana. 9 EPS Ana. |
Dec 2027 10 Rev. Ana. 10 EPS Ana. |
Dec 2028 8 Rev. Ana. 7 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
763.30M
est: 768.63M (-0.7%)
|
878.76M
est: 942.60M (-6.8%)
|
1.18B
est: 1.18B (+0.3%)
|
1.55B
est: 1.59B (-3.0%)
|
1.93B
est: 1.94B (-0.5%)
|
2.09B
est: 2.01B (+4.1%)
|
2.78B
est: 2.92B (-4.7%)
|
2.72B
est: 2.85B (-4.6%)
|
2.85B
est: 2.89B (-1.7%)
|
2.87B
est: 2.94B (-2.1%)
|
2.91B
est: 2.97B (-1.9%)
|
3.26B
3.04B – 3.54B
+9.8% YoY
|
3.61B
3.22B – 3.95B
+10.7% YoY
|
3.99B
3.98B – 4.01B
+10.7% YoY
|
| EBITDA |
223.66M
est: 237.78M (-5.9%)
|
224.24M
est: 291.59M (-23.1%)
|
334.53M
est: 363.76M (-8.0%)
|
496.30M
est: 493.04M (+0.7%)
|
690.08M
est: 600.56M (+14.9%)
|
712.99M
est: 620.63M (+14.9%)
|
1.00B
est: 902.71M (+10.9%)
|
816.57M
est: 882.02M (-7.4%)
|
779.55M
est: 887.54M (-12.2%)
|
779.18M
est: 900.14M (-13.4%)
|
955.05M
est: 909.92M (+5.0%)
|
999.55M
933.54M – 1.09B
+9.8% YoY
|
1.11B
987.79M – 1.21B
+10.7% YoY
|
1.22B
1.22B – 1.23B
+10.7% YoY
|
| EBIT |
185.76M
est: 215.30M (-13.7%)
|
176.88M
est: 264.03M (-33.0%)
|
285.01M
est: 329.38M (-13.5%)
|
440.01M
est: 446.44M (-1.4%)
|
629.29M
est: 543.79M (+15.7%)
|
650.34M
est: 561.97M (+15.7%)
|
929.37M
est: 817.38M (+13.7%)
|
734.97M
est: 798.65M (-8.0%)
|
694.35M
est: 767.91M (-9.6%)
|
691.34M
est: 778.81M (-11.2%)
|
691.63M
est: 787.28M (-12.1%)
|
864.83M
807.71M – 940.03M
+9.8% YoY
|
957.33M
854.66M – 1.05B
+10.7% YoY
|
1.06B
1.06B – 1.06B
+10.7% YoY
|
| Net Income |
124.42M
est: 161.72M (-23.1%)
|
136.16M
est: 177.17M (-23.1%)
|
216.57M
est: 210.38M (+2.9%)
|
332.09M
est: 305.16M (+8.8%)
|
466.12M
est: 470.20M (-0.9%)
|
492.63M
est: 527.00M (-6.5%)
|
702.81M
est: 737.54M (-4.7%)
|
548.27M
est: 647.18M (-15.3%)
|
500.44M
est: 505.87M (-1.1%)
|
501.43M
est: 512.80M (-2.2%)
|
501.95M
est: 504.99M (-0.6%)
|
568.48M
520.88M – 599.95M
+12.6% YoY
|
638.53M
552.72M – 690.98M
+12.3% YoY
|
719.89M
588.79M – 819.63M
+12.7% YoY
|
| SGA |
121.49M
est: 88.48M (+37.3%)
|
179.51M
est: 108.51M (+65.4%)
|
181.37M
est: 135.36M (+34.0%)
|
200.85M
est: 183.47M (+9.5%)
|
224.88M
est: 223.48M (+0.6%)
|
247.64M
est: 230.95M (+7.2%)
|
283.39M
est: 335.91M (-15.6%)
|
312.81M
est: 328.22M (-4.7%)
|
338.22M
est: 327.91M (+3.1%)
|
348.23M
est: 332.56M (+4.7%)
|
318.86M
est: 336.18M (-5.2%)
|
369.29M
344.90M – 401.40M
+9.8% YoY
|
408.79M
364.95M – 447.04M
+10.7% YoY
|
452.47M
450.65M – 454.30M
+10.7% YoY
|
| EPS |
0.39
est: 0.36 (+8.0%)
|
0.42
est: 0.40 (+6.1%)
|
0.68
est: 0.47 (+44.7%)
|
1.04
est: 0.68 (+52.6%)
|
1.04
est: 1.05 (-1.0%)
|
1.10
est: 1.18 (-6.6%)
|
1.56
est: 1.65 (-5.3%)
|
1.22
est: 1.45 (-15.6%)
|
1.12
est: 1.13 (-1.0%)
|
1.12
est: 1.18 (-5.3%)
|
1.12
est: 1.19 (-5.5%)
|
1.28
1.16 – 1.34
+8.2% YoY
|
1.44
1.24 – 1.54
+12.4% YoY
|
1.62
1.32 – 1.83
+12.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-20 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-19 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-18 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-15 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-14 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-13 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-12 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
604.06M
OE per share TTM
1.35
Owner's Yield
3.61%
Maintenance CapEx ratio
22.18%
Maint CapEx / Avg PPE
80.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 33 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF ASHS | 0.10% | 36.0K | 0.65% |
| 2 | Xtrackers Harvest CSI A500 UCITS ETF 1D AH50.L | 0.04% | 6.0K | 0.65% |
| 3 | Franklin FTSE China ETF FLCH | 0.01% | 33.4K | 0.19% |
| 4 | Franklin FTSE China UCITS ETF FLXC.L | 0.01% | 144.0K | 0.19% |
| 5 | Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF EMCR | 0.01% | 4.7K | 0.15% |
| 6 | Schwab Emerging Markets Equity ETF SCHE | 0.00% | 216.3K | 0.06% |
| 7 | Franklin FTSE Asia ex Japan ETF FLAX | 0.00% | 709.39 | 0.19% |
| 8 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 18.4K | 0.48% |
| 9 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 41.4K | 0.26% |
| 10 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 2.04M | 0.06% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
113.1K
Shares Outstanding
447.29M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Guoxi Xu | Chief Financial Officer & Accounting Supervisor | — | male |
| Hua Zhang | Secretary of the Board | — | male |
| Liang Hao | Company Representative | — | — |
| Yi Wang | GM & Chairman | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 600763.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
